A more prominent role of MCL-1 as compared to BCL-2 in AML is supported by genetic studies in which the deletion of MCL-1 but not BCL-2 or BCL-xL was shown to cure AML in animal models18. This evidence concerns the gene BCL2 and acute myeloid leukemia.